145,514 Shares in Alphatec Holdings Inc (ATEC) Purchased by Broadfin Capital LLC
Broadfin Capital LLC bought a new stake in Alphatec Holdings Inc (NASDAQ:ATEC) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 145,514 shares of the medical technology company’s stock, valued at approximately $387,000.
ATEC has been the subject of a number of recent analyst reports. Zacks Investment Research upgraded shares of Alphatec from a “sell” rating to a “hold” rating in a research report on Tuesday, January 23rd. ValuEngine lowered shares of Alphatec from a “sell” rating to a “strong sell” rating in a research report on Friday, December 1st. Finally, HC Wainwright reiterated a “buy” rating and issued a $4.00 target price on shares of Alphatec in a research report on Wednesday, November 22nd.
Alphatec Holdings Inc (NASDAQ ATEC) opened at $3.22 on Friday. The stock has a market cap of $53.35, a PE ratio of -1.96 and a beta of 1.42. The company has a debt-to-equity ratio of -1.11, a current ratio of 2.11 and a quick ratio of 1.08. Alphatec Holdings Inc has a 12-month low of $1.58 and a 12-month high of $5.80.
Alphatec Holdings, Inc is a medical technology company. The Company through its subsidiary, Alphatec Spine, Inc and its subsidiaries, designs, develops, manufactures and markets products for the surgical treatment of spine disorders. Its product portfolio and pipeline addresses the cervical, thoracolumbar and intervertebral regions of the spine and covers a range of spinal disorders and surgical procedures.
Want to see what other hedge funds are holding ATEC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Alphatec Holdings Inc (NASDAQ:ATEC).
Receive News & Ratings for Alphatec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alphatec and related companies with MarketBeat.com's FREE daily email newsletter.